NEDD4L-Mediated Ubiquitination of GPX4 Exacerbates Doxorubicin-Induced Cardiotoxicity
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26178201 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Jiaxing Ke und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Higher Educational Key Laboratory for Cardiovascular Disease of Fujian Province, Clinical Research Center for Metabolic Heart Disease of Fujian P…. Hauptthemen laut MEDLINE: Nedd4 Ubiquitin Protein Ligases, Doxorubicin, Ubiquitination, Cardiotoxicity. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Innovation Project of Fujian Province, China.
Abstract (Originalsprache)
Doxorubicin (DOX) is an anthracycline chemotherapeutic agent that is clinically limited by doxorubicin-induced cardiotoxicity (DIC), with ferroptosis and apoptosis identified as key mechanisms. As an antioxidant enzyme, GPX4 undergoes ubiquitin-mediated degradation during myocardial ischemia–reperfusion injury; however, the role of its ubiquitination in DIC remains unclear. This study revealed that GPX4 undergoes ubiquitinated degradation during DIC, exacerbating ferroptosis and apoptosis in cardiomyocytes. NEDD4L was found to interact with GPX4, and its expression was upregulated in DOX-treated mouse myocardial tissues and cardiomyocytes. NEDD4L knockdown alleviated DIC, as well as ferroptosis and apoptosis in cardiomyocytes. Mechanistically, NEDD4L recognizes GPX4 through its WW domain and mediates K48-linked ubiquitination and degradation of GPX4 under DOX stimulation via its HECT domain. Knockdown of NEDD4L reduced DOX-induced GPX4 ubiquitination levels and subsequent degradation. Notably, while NEDD4L knockdown mitigated DOX-induced cell death, concurrent GPX4 knockdown attenuated this protective effect, indicating that GPX4 is a key downstream target of NEDD4L in regulating cardiomyocyte death. These findings identify NEDD4L as a potential therapeutic target for preventing and treating DIC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Higher Educational Key Laboratory for Cardiovascular Disease of Fujian Province, Clinical Research Center for Metabolic Heart Disease of Fujian Province, Cardiovascular Department, The First Affiliated Hospital, Fuj…
ORCID-Profile: Lingjia Li, Feng Peng, Jinxiu Lin
Förderung
- Medical Innovation Project of Fujian Province, China
Zitieren
APA
Ke, J., Li, L., Chen, S., Liao, C., Peng, F., Chai, D., & Lin, J. (2025). NEDD4L-Mediated Ubiquitination of GPX4 Exacerbates Doxorubicin-Induced Cardiotoxicity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178201
Vancouver
Ke J, Li L, Chen S, Liao C, Peng F, Chai D, et al. NEDD4L-Mediated Ubiquitination of GPX4 Exacerbates Doxorubicin-Induced Cardiotoxicity. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178201
BibTeX
@article{Ke2025,
author = {Ke, Jiaxing and Li, Lingjia and Chen, Shuling and Liao, Chenxin and Peng, Feng and Chai, Dajun and Lin, Jinxiu},
title = {NEDD4L-Mediated Ubiquitination of GPX4 Exacerbates Doxorubicin-Induced Cardiotoxicity},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26178201}
}
EUVIMED